Clinical Trial Update: OPC5: Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) in Patients With Malignant Pleural Effusion. [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating OPC5 delivered as a pressurized intrathoracic aerosol chemotherapy (PITAC) for malignant pleural effusion and pleural neopla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Effusion
• Pleural Carcinomatosis
• Pleural Neoplasms

Drugs mentioned

• OPC5

Snippet

Sponsor: Odense University Hospital | Conditions: Malignant Pleural Effusion, Pleural Neoplasms | Phase 1 | Status: RECRUITING